Enhanced Retention of NTSR1-Targeted Radionuclide Therapeutics via Covalent Inhibitors in Pancreatic, Colorectal, and Prostate Cancer Models.

Lu 177 zalsenertant tetraxetan (177Lu-IPN01087) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/40101018

Abhijit Aithal; Alireza Basiri; Jered C Garrison; Katie Brake; Lynette M Smith; Maneesh Jain; Megan A Hyun; Subodh M Lele; Wei Fan; Wenting Zhang

Mar 18, 2025